Extranodal NK/T-cell lymphoma nasal-type with an unusual location in the oropharynx
DOI:
https://doi.org/10.34631/sporl.251Keywords:
T/NK cell lymphoma, oropharynxAbstract
NK/T-cell lymphoma is a rare subtype of lymphoma of the sinonasal tract, previously known as lethal midline granuloma. lt is characterized by the progressive destructíon of midfacial structures.
We report the case of a 43 year old woman with NK/T-cell lymphoma, nasal-type with an extremely unusual locatíon in the oropharynx. Despite of being rare, there are well defined therapeutíc modalitíes available in the management of this type of tumours. However, the prognosis is usually poor.
References
McBride P. Photographs of a case of rapid destruction of the nose and face. J Laryngol Otol 1897; 12: 64-66.
Vidal RW et al. Sinonasal malignant lymphomas: a distinct clinicopa-thological category. Ann Otol Rhinol Laryngol 1999; 108(4): 411-9.
Cheung MM, Chan JK, Lau, Foo W. Primary non-Hodgkin lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. JClin Oncology 1998; 16:70-7.
Harris NL, Jaffe ES, Stein HS, Banks PM, Chan JKC, Cleary ML, et al. A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood
; 84: 1361-92.
Yoshifumi I et al. Nasal T-cell lymphoma as a type of so-called "Lethal midline granuloma". Cancer 1982; 50: 2336-2344.
Tsokos M, Fauci AS, Costa J, Idiopathic midline destructive disease (IMDD). A subgroup of patients with the "midline granuloma" syndrome. Am J Clin Pathol 1982; 77: 162-8.
Senan S. Malignant centrofacial granulomas. Laryngoscope 1992. 102(4): 472.
Chan J, Ng CS, Lau WH, Stephen TH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987; 11:418-29.
Hartig G, Montone K, Wasik M, Chalian A, Hayden R. Nasal T-cell lymphoma and the lethal midline granuloma syndrome. Otolaryngol Head Neck Surg 1996; 114: 653-656.
Cleary KR, Batsakis JG. Sinonasal lymphomas. Ann Otol Rhinol Laryngol 1994; 103: 911-914.
Petrella T, Delfau-Larue MH, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer origin. Hum Pathol 1996; 27: 827-33.
Harabuchi Y et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. The Lancet1990; 20:128-130.
Peiper SC. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein-Barr virus in pathogenesis. Blood 1993; 82: 687-90.
Nagata H, et al. Characterization of novel natural killer (NK)-cell and yõ T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 2001. 97(3): 708-13.
Braunwald E et al., Harrison's Principles of Internal Medicine. 15th ed. Chapter 112. Malignancies of Lymphoid Cells. McGaw-Hill 2001. 715-727.
Myamoto T, Yoshino T, Takehisa T, et al. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases. Int J Dermatol 1997; 36(6): 419-27.
Cummings CW, Donegan J. Otolaryngology - Head and Neck Surgery. Mosby 1993, Chapter 93 - Lymphomas 1758-1763.
Borges A et al. Midline destructive lesions of the sinonasal tract: Simplified terminology based on histopathologic criteria. AJNR Am J Neuroradiol 2000; 21: 331-336.
Skarin A. Lethal midline granuloma revisited: Nasal T/ Natural-Killer cell lymphoma. J Clin Oncology 1999; 17: 1322-1325.
Miller TP, Dahlberg MS, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin lymphoma. N Eng J Med 1998; 339: 21-6.
